Heilongjiang ZBD Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Heilongjiang ZBD Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Chengdu Kanghong Pharmaceutical Group Co Ltd
sales of 3.26 billion Chinese Renmimbi [US$460.63 million]
of which 100%
was Pharmaceutical Manufacturing),
Guizhou Yibai Pharmaceutical Co., Ltd.
(3.36 billion Chinese Renmimbi [US$475.32 million]
of which 83%
was Medical Industry), and
Anhui Fengyuan Pharmaceutical
(3.24 billion Chinese Renmimbi [US$457.93 million]
of which 51%
was Medicine Manufacturing).
Heilongjiang ZBD Pharmaceutical Co Ltd reported sales of 3.29 billion Chinese Renmimbi (US$465.52 million)
December of 2019.
increase of 18.3%
versus 2018, when the company's sales were 2.78 billion Chinese Renmimbi.
Sales of Other Operations saw an increase
that was more than double the company's growth rate: sales were up
144.9% in 2019, from
142.15 million Chinese Renmimbi to 348.09 million Chinese Renmimbi.
Heilongjiang ZBD Pharmaceutical Co Ltd also saw significant increases in sales in
Pharmaceutical Business (up 75.1% to 903.99 million Chinese Renmimbi)
Not all segments of Heilongjiang ZBD Pharmaceutical Co Ltd experienced an increase in sales in 2019:
sales of Pharmaceutical Industry fell 3.9% to 2.04 billion Chinese Renmimbi.